FI902415A0 - Oxadiazolderivat och dess salter, anvaendning av dessa vid behandling av demens, framstaellning och formulationer. - Google Patents

Oxadiazolderivat och dess salter, anvaendning av dessa vid behandling av demens, framstaellning och formulationer.

Info

Publication number
FI902415A0
FI902415A0 FI902415A FI902415A FI902415A0 FI 902415 A0 FI902415 A0 FI 902415A0 FI 902415 A FI902415 A FI 902415A FI 902415 A FI902415 A FI 902415A FI 902415 A0 FI902415 A0 FI 902415A0
Authority
FI
Finland
Prior art keywords
och
oxadiazolderivat
formulationer
demens
dessa
Prior art date
Application number
FI902415A
Other languages
English (en)
Inventor
Graham Andrew Showell
Leslie Joseph Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898911079A external-priority patent/GB8911079D0/en
Priority claimed from GB898923015A external-priority patent/GB8923015D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of FI902415A0 publication Critical patent/FI902415A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
FI902415A 1989-05-15 1990-05-15 Oxadiazolderivat och dess salter, anvaendning av dessa vid behandling av demens, framstaellning och formulationer. FI902415A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898911079A GB8911079D0 (en) 1989-05-15 1989-05-15 Therapeutic agents
GB898923015A GB8923015D0 (en) 1989-10-12 1989-10-12 Therapeutic agents

Publications (1)

Publication Number Publication Date
FI902415A0 true FI902415A0 (fi) 1990-05-15

Family

ID=26295353

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902415A FI902415A0 (fi) 1989-05-15 1990-05-15 Oxadiazolderivat och dess salter, anvaendning av dessa vid behandling av demens, framstaellning och formulationer.

Country Status (10)

Country Link
US (1) US5106853A (fi)
EP (1) EP0398629A3 (fi)
JP (1) JPH0363280A (fi)
KR (1) KR900018087A (fi)
AU (1) AU5506790A (fi)
CA (1) CA2016708A1 (fi)
FI (1) FI902415A0 (fi)
IL (1) IL94404A0 (fi)
NO (1) NO902156L (fi)
PT (1) PT94026A (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8911080D0 (en) * 1989-05-15 1989-06-28 Merck Sharp & Dohme Chemical process
EP0456310A3 (en) * 1990-05-09 1992-03-04 Merck Sharp & Dohme Ltd. Enantioselective synthesis of 3-substituted 1-azabicyclo (2.2.1)heptanes
US5124460A (en) * 1991-05-06 1992-06-23 Merck Sharp & Dohme Ltd. Enantioselective synthesis of 3-substituted 1-azabicyclo (2.2.1)heptanes
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
US6060473A (en) * 1993-04-01 2000-05-09 Ucb S.A. - Dtb 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands
AU701227B2 (en) 1993-09-10 1999-01-21 Cytomed, Inc Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
US6117889A (en) * 1994-04-01 2000-09-12 University Of Virginia 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
EP1200440A1 (en) 1999-07-06 2002-05-02 Vertex Pharmaceuticals Incorporated Quinuclidine derivatives for treatment of neurological disorders
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
JP2005522457A (ja) * 2002-02-26 2005-07-28 ノース ショア−ロング アイランド ジューイッシュ リサーチ インスティチュート 脳ムスカリン性レセプターの刺激による炎症性サイトカイン産生の阻害
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
JP2007530586A (ja) * 2004-03-25 2007-11-01 ザ ファインスタイン インスティテュート フォー メディカル リサーチ 神経性止血法
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
ATE489132T1 (de) 2004-12-27 2010-12-15 The Feinstein Inst Medical Res Behandlung von entzündlichen erkrankungen durch elektrische stimulation des vagus-nervs
WO2009029614A1 (en) * 2007-08-27 2009-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US9211409B2 (en) * 2008-03-31 2015-12-15 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of T-cell activity
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US20090275997A1 (en) * 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
AU2009316801C1 (en) 2008-11-18 2015-12-24 Setpoint Medical Corporation Devices and methods for optimizing electrode placement for anti-inflammatory stimulation
US8886339B2 (en) 2009-06-09 2014-11-11 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8788034B2 (en) 2011-05-09 2014-07-22 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
EP3636314B1 (en) 2009-12-23 2021-09-08 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en) 2015-02-03 2022-08-09 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
WO2017127758A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
WO2017127756A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Control of vagal stimulation
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
WO2019036470A1 (en) 2017-08-14 2019-02-21 Setpoint Medical Corporation TESTING TEST FOR STIMULATION OF NERVE WAVE
US11660443B2 (en) 2018-04-20 2023-05-30 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via electrical trigeminal nerve stimulation
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US11938324B2 (en) 2020-05-21 2024-03-26 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
NZ226000A (en) * 1987-09-10 1991-06-25 Merck Sharp & Dohme Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
IL88846A0 (en) * 1988-01-08 1989-07-31 Merck Sharp & Dohme Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO902156D0 (no) 1990-05-15
AU5506790A (en) 1990-11-15
CA2016708A1 (en) 1990-11-15
KR900018087A (ko) 1990-12-20
PT94026A (pt) 1991-01-08
EP0398629A3 (en) 1991-12-11
IL94404A0 (en) 1991-03-10
EP0398629A2 (en) 1990-11-22
JPH0363280A (ja) 1991-03-19
US5106853A (en) 1992-04-21
NO902156L (no) 1990-11-16

Similar Documents

Publication Publication Date Title
FI902415A0 (fi) Oxadiazolderivat och dess salter, anvaendning av dessa vid behandling av demens, framstaellning och formulationer.
FI894148A0 (fi) Raomaterial, foerfarande foer dess framstaellning och dess anvaendning.
FI921326A0 (fi) Vattendispersion av sjaelvledande polyalkoxitiofener, foerfarande foer dess framstaellning och dess anvaendning.
FI904825A0 (fi) Nukleinsyratestartikel och dess anvaendning vid paovisning av pao foerhand bestaemd nukleinsyra.
FI904877A0 (fi) 9a-hydroxi-17-metylensteroider, foerfarande foer deras framstaellning och deras anvaendning vid framstaellning av kortikosteroider.
FI900537A0 (fi) Elektricitet ledande resistmassa, foerfarande foer dess framstaellning och dess anvaendning.
FI884823A0 (fi) Virusantigen, foerfarande foer dess framstaellning och anvaendning vid diagnos och terapi.
FI892709A0 (fi) Turbulensgenerator i inloppslaodan av en pappersmaskin.
FI895658A0 (fi) Titandioxid, foerfarande foer dess framstaellning och dess anvaendning.
FI894742A (fi) Elledande plastkomposit, dess anvaendning och framstaellning.
FI893244A (fi) Foerfarande och anordning foer upptagning av stroemstoetar vid aoskledare, oeverspaenningsskydd och dylika.
FI892385A0 (fi) Munstyckessystem i blaosningslaodan av en pappersmaskin.
FI895742A0 (fi) Pao mineralfibrer baserad blandmaterial, anordning foer dess tillverkning och tillaempning av blandmaterialet.
FI895659A0 (fi) Titandioxid, foerfarande foer dess framstaellning och dess anvaendning.
FI903101A (fi) Antistatisk, belaeggningskomposition, foerfarande foer dess framstaellning och antistatisk, blaendfri bildrutedisplay vid belaeggningskompositionens anvaendning.
FI895462A0 (fi) Reninhaemmande urinaemne-derivat av dipeptid, foerfarande foer dess framstaellning, detta innehaollande aemne och dessa anvaendning.
FI895567A0 (fi) 2-azabicyklo /2,2,1 / hept-5-en-2 -etikssyra, dess derivat och beslaektade foereningar, foerfarande foer framstaellning av naemnda foereningar och anvaendning av naemnda foereningar vid framstaellning av n-fosfonometylglycin.
FI905406A0 (fi) Formkropp av cellplast och foerfarande foer dess framstaellning.
FI891313A0 (fi) Foerfarande foer framstaellning av en polymerisationskatalysatorkomponent, en medelst foerfarandet framstaelld polymerisationskatalysatorkomponent och dess anvaendning.
FI903790A0 (fi) Fluoranfoerening, foerfarande foer dess framstaellning och denna foerening innehaollande vaermekaensliga upptagningsmaterial.
FI894149A (fi) Pao polyfenylenoxid och en vinylaromatisk foerening baserat skumbart polymerisat, foerfarande foer dess framstaellning och dess anvaendning.
FI921687A0 (fi) Oxideringsfaergningsmedel, dess framstaellning och anvaendning.
FI892352A0 (fi) Foer olefinpolymerisation aegnad katalysatorkomponent, dess framstaellning och anvaendning.
FI903457A0 (fi) Foerfarande foer framstaellning av n,n-dimetylaminometylarylfoereningar.
FI892380A0 (fi) Anordning foer foerflyttning i sidled av en rulle ingaoende i en foerflyttningsanordning.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: MERCK SHARP & DOHME LIMITED